Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10571730rdf:typepubmed:Citationlld:pubmed
pubmed-article:10571730lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0680220lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0221920lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0221198lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0263361lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C1420652lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C1423842lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0242568lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0175630lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C0444706lld:lifeskim
pubmed-article:10571730lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:10571730pubmed:issue5lld:pubmed
pubmed-article:10571730pubmed:dateCreated1999-12-8lld:pubmed
pubmed-article:10571730pubmed:abstractTextPsoriasis vulgaris is a skin disease potentially mediated by pro-inflammatory cytokines produced by type 1 lesional T cells. The capability of individual T cells to produce these cytokines in lesional skin is not known. In this study we measured the ability of lesional and peripheral blood T cells to produce intracellular interferon-gamma, tumor necrosis factor-alpha, interleukin-2, interleukin-4, and interleukin-10 proteins as detected by flow cytometric analysis. Cytokine synthesis was induced by activation with ionomycin/phorbol myristate acetate (in the presence of Brefeldin A, which inhibits the exocytosis of these cytokines). After stimulation, we found relatively high percentages of epidermal CD8 and CD4 T cells capable of producing interferon-gamma, tumor necrosis factor-alpha, and interleukin-2, whereas few T cells, < 11%, expressed interleukin-4 or interleukin-10. Hence both CD8+ and CD4+ T cells are capable of type 1 effector functions (TC1 and TH1, respectively). This activation scheme was repeated on peripheral blood T cells from psoriatic patients versus healthy controls, where we also found a type 1 bias. In order to evaluate quantitatively the type 1 cytokine bias, we compared the frequency of type 2 interleukin-4 producing versus type 1 interferon-gamma producing T cells in our assay and found a shift towards type 1 producing cells. This shift reveals a type 1 differentiation bias in both lesional areas and in the peripheral blood, which may indicate an imbalance within the T cell population, which is contributing to the chronic or sustained immunologic activation of T cells found in this disease.lld:pubmed
pubmed-article:10571730pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:languageenglld:pubmed
pubmed-article:10571730pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:citationSubsetIMlld:pubmed
pubmed-article:10571730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10571730pubmed:statusMEDLINElld:pubmed
pubmed-article:10571730pubmed:monthNovlld:pubmed
pubmed-article:10571730pubmed:issn0022-202Xlld:pubmed
pubmed-article:10571730pubmed:authorpubmed-author:OzawaMMlld:pubmed
pubmed-article:10571730pubmed:authorpubmed-author:KikuchiTTlld:pubmed
pubmed-article:10571730pubmed:authorpubmed-author:KruegerJ GJGlld:pubmed
pubmed-article:10571730pubmed:authorpubmed-author:AustinL MLMlld:pubmed
pubmed-article:10571730pubmed:authorpubmed-author:WaltersI BIBlld:pubmed
pubmed-article:10571730pubmed:issnTypePrintlld:pubmed
pubmed-article:10571730pubmed:volume113lld:pubmed
pubmed-article:10571730pubmed:ownerNLMlld:pubmed
pubmed-article:10571730pubmed:authorsCompleteYlld:pubmed
pubmed-article:10571730pubmed:pagination752-9lld:pubmed
pubmed-article:10571730pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:meshHeadingpubmed-meshheading:10571730...lld:pubmed
pubmed-article:10571730pubmed:year1999lld:pubmed
pubmed-article:10571730pubmed:articleTitleThe majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients.lld:pubmed
pubmed-article:10571730pubmed:affiliationlaboratory of Investigative Dermatology, The Rockerfeller University, New York, New York 10021-6399, USA. austinl@rockvax.rockerfeller.edulld:pubmed
pubmed-article:10571730pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10571730pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10571730pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10571730pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10571730lld:pubmed